A carregar...
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan or (131)I-Tositumomab
This study aimed at identifying clinical factors for predicting hematologic toxicity after radioimmunotherapy with (90)Y-ibritumomab tiuxetan or (131)I-tositumomab in clinical practice. METHODS: Hematologic data were available from 14 non-Hodgkin lymphoma patients treated with (90)Y-ibritumomab tiux...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3169802/ https://ncbi.nlm.nih.gov/pubmed/21098795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.110.079947 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|